Mr. Martin LeBlanc becomes a Director of Victhom
Victhom Human Bionics Inc. announced that Mr. Martin LeBlanc had joined its Board of Directors on March 23rd, 2007. "Mr. LeBlanc will be bringing exceptional expertise to Victhom, and his experience will be especially relevant and useful for the future development of the Company" said Mr. Daniel Johnson, Chairman of the Board.
Mr. LeBlanc is currently President of Caprion Proteomics. He was a Co-founder of Caprion Pharmaceuticals and served as its Chief Operating Officer from 2000 to 2007. Prior to that, he was successively a management consultant with McKinsey & Company, VP of Sales & Marketing at Advanced Bioconcept Ltd. and its General Manager after its acquisition by NEN Life Sciences (now Perkin-Elmer). He is also Co-chair of Montreal In-Vivo, and a member of the Board of Directors of the Atlantic Cancer Research Institute. Mr. LeBlanc holds a B.Sc.Soc. from the University of Moncton (N.-B.) and an M.A. from Oxford University where he was a Rhodes Scholar.
Mr. André Monette has decided not to seek re-election for the position of Director at the next annual meeting, and he has chosen to leave the Board of Directors on April 2, 2007.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
